Countdown to Ethereum Pectra Upgrade Activation: Learn more
$2.73T
Total marketcap
$49.32B
Total volume
BTC 60.03%     ETH 7.80%
Dominance

Niagen Bioscience CDXC Stock

7.87 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
NasdaqCM
Market Cap
611.9M USD
LOW - HIGH [24H]
0.0000 - 0.0000 USD
VOLUME [24H]
0 USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Niagen Bioscience Price Chart

Niagen Bioscience CDXC Financial and Trading Overview

Niagen Bioscience stock price 7.87 USD
Previous Close 1.74 USD
Open 1.72 USD
Bid 0 USD x 800
Ask 0 USD x 1000
Day's Range 1.65 - 1.77 USD
52 Week Range 1.15 - 2.28 USD
Volume 132.26K USD
Avg. Volume 105.13K USD
Market Cap 125.19M USD
Beta (5Y Monthly) 1.790492
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 5.17 USD

CDXC Valuation Measures

Enterprise Value 111.86M USD
Trailing P/E N/A
Forward P/E -27.833334
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.6185938
Price/Book (mrq) 4.4652405
Enterprise Value/Revenue 1.446
Enterprise Value/EBITDA -9.487

Trading Information

Niagen Bioscience Stock Price History

Beta (5Y Monthly) 1.790492
52-Week Change 1.82%
S&P500 52-Week Change 20.43%
52 Week High 2.28 USD
52 Week Low 1.15 USD
50-Day Moving Average 1.47 USD
200-Day Moving Average 1.59 USD

CDXC Share Statistics

Avg. Volume (3 month) 105.13K USD
Avg. Daily Volume (10-Days) 96.45K USD
Shares Outstanding 74.97M
Float 47.76M
Short Ratio 20.28
% Held by Insiders 41.87%
% Held by Institutions 15.56%
Shares Short 1.54M
Short % of Float 2.77%
Short % of Shares Outstanding 2.04%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:3

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -13.83%
Operating Margin (ttm) -16.63%
Gross Margin 59.19%
EBITDA Margin -15.24%

Management Effectiveness

Return on Assets (ttm) -15.070%
Return on Equity (ttm) -39.71%

Income Statement

Revenue (ttm) 77.35M USD
Revenue Per Share (ttm) 1.08 USD
Quarterly Revenue Growth (yoy) 30.69%
Gross Profit (ttm) 42.8M USD
EBITDA -11790000 USD
Net Income Avi to Common (ttm) -10702000 USD
Diluted EPS (ttm) -0.16
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 22.99M USD
Total Cash Per Share (mrq) 0.31 USD
Total Debt (mrq) 4.09M USD
Total Debt/Equity (mrq) 14.59 USD
Current Ratio (mrq) 2.528
Book Value Per Share (mrq) 0.374

Cash Flow Statement

Operating Cash Flow (ttm) -5108000 USD
Levered Free Cash Flow (ttm) -1725000 USD

Profile of Niagen Bioscience

Country United States
State CA
City Los Angeles
Address 10900 Wilshire Blvd
ZIP 90024
Phone 310-388-6706
Website https://www.chromadex.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 113

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.

Q&A For Niagen Bioscience Stock

What is a current CDXC stock price?

Niagen Bioscience CDXC stock price today per share is 7.87 USD.

How to purchase Niagen Bioscience stock?

You can buy CDXC shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Niagen Bioscience?

The stock symbol or ticker of Niagen Bioscience is CDXC.

Which industry does the Niagen Bioscience company belong to?

The Niagen Bioscience industry is Biotechnology.

How many shares does Niagen Bioscience have in circulation?

The max supply of Niagen Bioscience shares is 77.75M.

What is Niagen Bioscience Price to Earnings Ratio (PE Ratio)?

Niagen Bioscience PE Ratio is 0.00000000 now.

What was Niagen Bioscience earnings per share over the trailing 12 months (TTM)?

Niagen Bioscience EPS is 0 USD over the trailing 12 months.

Which sector does the Niagen Bioscience company belong to?

The Niagen Bioscience sector is Healthcare.

Niagen Bioscience CDXC included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 15587.79 USD
-5.82
9.14B USD 15575.68 USD 16128.16 USD 9.14B USD
NASDAQ Industrial INDS 9888.95 USD
-5.72
9881.85 USD 10226.45 USD
NASDAQ Capital Market Composite RCMP 92.16 USD
-4.45
89.57 USD 93.85 USD
NASDAQ HealthCare IXHC 869.8 USD
-5.51
868.74 USD 900.72 USD